Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy.
Ontology highlight
ABSTRACT: Cisplatin and other platinum-based chemotherapeutic drugs have been used extensively for the treatment of human cancers such as bladder, blood, breast, cervical, esophageal, head and neck, lung, ovarian, testicular cancers, and sarcoma. Cisplatin is commonly administered intravenously as a first-line chemotherapy for patients suffering from various malignancies. Upon absorption into the cancer cell, cisplatin interacts with cellular macromolecules and exerts its cytotoxic effects through a series of biochemical mechanisms by binding to Deoxyribonucleic acid (DNA) and forming intra-strand DNA adducts leading to the inhibition of DNA synthesis and cell growth. Its primary molecular mechanism of action has been associated with the induction of both intrinsic and extrinsic pathways of apoptosi
SUBMITTER: Tchounwou PB
PROVIDER: S-EPMC7987268 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA